-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NOoS0SUaOUIvZ+Lx9WBYX/vEu9rFueEEzfNlUCTWgiJ0c/+lFb8LqQTJtCO8cPJd ClHUh7laNCK8ZPZvIr7Bvw== 0001140361-11-012586.txt : 20110228 0001140361-11-012586.hdr.sgml : 20110228 20110228144340 ACCESSION NUMBER: 0001140361-11-012586 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110225 FILED AS OF DATE: 20110228 DATE AS OF CHANGE: 20110228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: END WILLIAM T CENTRAL INDEX KEY: 0001184157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 11645190 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 FORMER NAME: FORMER CONFORMED NAME: END WILLIAM DATE OF NAME CHANGE: 20020829 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0303 4 2011-02-25 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001184157 END WILLIAM T ONE IDEXX DRIVE WESTBROOK ME 04092 1 0 0 0 Common Stock 2011-02-25 4 S 0 5000 75.8002 D 23063 D The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $75.67 to $75.976, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. John B. Rogers, Attorney-in-Fact for William T. End 2011-02-28 -----END PRIVACY-ENHANCED MESSAGE-----